KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals to Present at SVB Leerink 9th Annual Global Healthcare Conference Feb 19, 2020 KalVista Pharmaceuticals Provides Update on Diabetic Macular Edema Programs Feb 10, 2020 KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise Jan 13, 2020 All News
KalVista Pharmaceuticals to Present at SVB Leerink 9th Annual Global Healthcare Conference Feb 19, 2020
